Literature DB >> 1637398

Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism.

Z Kraiem1, E Baron, L Kahana, O Sadeh, M Sheinfeld.   

Abstract

We report a patient who underwent, over a mere 3-year period, three successive cycles of oscillation from hypo to hyper-thyroidism and back to hypothyroidism. This unusual sequence of events originated in a rare passage of primary hypothyroidism to hyper-thyroidism. The hyperthyroidism seemed typical of the autoimmune subgroup of toxic multinodular goitre. Stimulating and blocking TSH receptor antibody activities were measured (by cAMP functional bioassays using cultured human thyrocytes) during the course of the fluctuating phases of hypo and hyper-thyroidism. Measurement of such antibody activities revealed the coexistence of both stimulatory and blocking types of antibody in several serum samples from the patient. Throughout the whole course of alterations in thyroid function, thyroid stimulating antibodies were present. This was not the case with thyrotrophin receptor antibodies exhibiting TSH antagonist activity which seemed to appear and disappear. Monitoring such activity indicated that the emergence of blocking antibody seems to herald the onset of hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637398     DOI: 10.1111/j.1365-2265.1992.tb00960.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  14 in total

1.  Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism.

Authors:  M Gola; M Doga; G Mazziotti; S Bonadonna; A Giustina
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

2.  [Manifestations of autoimmune disorders in otorhinolaryngology : Classical symptoms and diagnostic approach].

Authors:  B Hofauer; A Chaker; K Thürmel; A Knopf
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

Review 3.  The measurement of antithyroid autoantibodies in the diagnosis and management of thyroid autoimmune disease.

Authors:  Z Kraiem
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

5.  Role of self-tolerance and chronic stimulation in the long-term persistence of adenovirus-induced thyrotropin receptor antibodies in wild-type and transgenic mice.

Authors:  Sandra M McLachlan; Holly A Aliesky; Chun-Rong Chen; Basil Rapoport
Journal:  Thyroid       Date:  2012-07-24       Impact factor: 6.568

6.  The clinical phenotype of Graves' disease occurring as an isolated condition or in association with other autoimmune diseases.

Authors:  M Rotondi; C Virili; S Pinto; F Coperchini; L Croce; N Brusca; M Centanni; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-08-12       Impact factor: 4.256

7.  Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

Authors:  L Chiovato; P Vitti; G Bendinelli; F Santini; E Fiore; A Capaccioli; M Tonacchera; C Mammoli; M Ludgate; A Pinchera
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

8.  The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.

Authors:  Chun-Rong Chen; Pavel Pichurin; Yuji Nagayama; Francesco Latrofa; Basil Rapoport; Sandra M McLachlan
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  Autoimmune thyroid disease with fluctuating thyroid function.

Authors:  Ali S Alzahrani; Saleh Aldasouqi; Suzan Abdel Salam; Ali Sultan
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

10.  ALTERNATING THYROID STATUS BETWEEN THYROTOXICOSIS AND HYPOTHYROIDISM IN A PATIENT WITH VARYING ANTITHYROID ANTIBODIES.

Authors:  Isaac Solaimanzadeh; Muhammad Rajib Hossain; Zewge Shiferaw-Deribe; Hargeet Sandhu
Journal:  AACE Clin Case Rep       Date:  2018-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.